Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-030999
Filing Date
2025-06-12
Accepted
2025-06-12 16:28:00
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749760072.html 4  
1 FORM 4 wk-form4_1749760072.xml 4 5924
  Complete submission text file 0001628280-25-030999.txt   7691
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Issuer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
HARRIGAN EDMUND (Reporting) CIK: 0001177917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12400 | Film No.: 251043140